Genuity Science Investor
Some of the world's most advanced clinico-omic data and insights to enable better disease discovery to improve human health.
Funding Status:
M&A
Industry:
End-to-End Drug Development
Estimated Revenue:
$10M to $50M
Technology:
Cancer
Acquisitions Number:
Made Acquisitions, Was Acquired
Headquarters:
Boston, Massachusetts, United States
Total Funding:
455000000.0
Last Funding Date:
2018-11-27
Last Funding Type:
Series C
Employee Number:
101-250
Investors Number:
8.0
Zip:
NA
Founded Date:
2013-01-01